Search

everythinglearnresearchcommunity

for

Search:↓

Using trait prevalence priors in genetic prediction models for appearance traits is currently impractical due to limited knowledge and potential accuracy issues.

Mesenchymal stem cells and their vesicles may effectively treat skin diseases, but more research is needed.

EDA2R is a key gene linked to ageing and diseases, and targeting it may help treat conditions like hair loss and chronic diseases.

The research found no clear link between the severity of male baldness and the scalp examination findings in Indonesian men.

Females have a higher lifetime risk of alopecia areata than males.

Keratin proteins are increasingly recognized as important for cell health and are linked to many diseases.

Modulating Cytochrome P450 activity could help develop new skin disease treatments.

Understanding tissue self-organization can improve treatments for diseases and advance regenerative medicine.

The data set helps improve predictions of how substances are absorbed through pig skin.

MicroRNAs could help assess and manage multiple chronic diseases.

Ginsenoside compound K shows promise for treating metabolic diseases like diabetes and obesity.

Adenosine receptors could be promising targets for treating inflammatory skin diseases like psoriasis.

Unique microRNA patterns can help diagnose and treat severe alopecia areata.

Targeting endolysosomes may help treat COVID-19.

The model helps understand scar contraction and develop new treatments.

Improving blood flow and oxygen levels in middle age may help prevent age-related diseases.

Hair manganese may relate to cardiometabolic health, not coronary artery disease severity.

Alopecia areata affects about 1.93% of people worldwide, with more women affected than men.

The skin microenvironment significantly affects hair growth and loss, offering potential treatment avenues.

The mutation causing Hutchinson-Gilford progeria syndrome leads to severe skin problems and early death in mice.

Social support improves empowerment and quality of life for breast cancer patients with hair loss.

Cholesterol- and phospholipid-free niosomes improve deep skin drug delivery.

CCCA may be a fibroproliferative disorder, and anti-fibrotic therapies could help.

Scientists found out the structure of a human enzyme linked to prostate cancer and hair loss, which could help in designing drugs.

When skin blisters, healing the wound is more important than growing hair, and certain stem cells mainly fix the blisters without helping hair growth.

Fibroblast state switching is crucial for skin healing and development.

3D-printed microneedles improve drug delivery and diagnostics but face scalability and regulatory challenges.